fluorodeoxyglucose f18 has been researched along with Basal Ganglia Diseases in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.90) | 18.7374 |
| 1990's | 7 (24.14) | 18.2507 |
| 2000's | 13 (44.83) | 29.6817 |
| 2010's | 6 (20.69) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Cajanus, A; Haapasalo, A; Hartikainen, P; Heikkinen, S; Katisko, K; Krüger, J; Remes, AM; Solje, E; Vanninen, R | 1 |
| Azulay, JP; Boucekine, M; Eusebio, A; Fluchère, F; Grimaldi, S; Guedj, E; Renaud, M; Witjas, T | 1 |
| Crivellaro, C; Ferrarese, C; Ferri, F; Grisanti, SG; Isella, V; Morzenti, S; Musarra, M | 1 |
| Allen, PJ; Amtage, F; Eidelberg, D; Feigin, A; Hanspal, E; Heinen, L; Hellwig, S; Leenders, KL; Meyer, PT; Niethammer, M; Poston, KL; Tang, CC; Vonsattel, JP | 1 |
| Alongi, P; Caminiti, SP; Cerami, C; Comi, G; Gianolli, L; Majno, L; Perani, D; Volontè, MA | 1 |
| Chung, SJ; Im, KC; Kim, JS; Kim, MJ; Lee, JH; Lee, MC; Oh, SJ; Park, HK | 1 |
| Almubarak, S; Gan, YC; Goddard, K; Hendson, G; Hukin, J; Nadel, H; Poskitt, K; Steinbok, P | 1 |
| Go, SM; Kim, EJ; Na, DL; Roh, JH; Seo, SW; Suh, MK | 1 |
| Cerhan, JH; Gavrilova, RH; Josephs, KA; Passov, V; Strand, E | 1 |
| Barthel, H; Grahmann, F; Hermann, W; Hesse, S; Kühn, HJ; Villmann, T; Wagner, A | 1 |
| Coulier, IM; de Vries, JJ; Leenders, KL | 1 |
| Hsu, JL; Shen, YY; Wang, HC | 1 |
| Benke, T; Delazer, M; Donnemiller, E; Karner, E; Marksteiner, J; Seppi, K | 1 |
| Biebl, W; Donnemiller, E; Moncayo, R; Ott, HW | 1 |
| Hsu, JL; Hsu, WC; Wang, HC | 1 |
| Hummel, T; Kitzler, H; Landis, B; Mueller, A; Reichmann, H; Reuner, U | 1 |
| Chabot, B; Defer, GL; Lalevée, C; Le Ber, I; Marié, RM | 1 |
| Cavanna, AE; Trimble, MR | 1 |
| Biraben, A; Bouilleret, V; Chassoux, F; Mantzaridez, M; Ribeiro, MJ; Semah, F; Trebossen, R | 1 |
| Kuhl, DE | 1 |
| Dhawan, V; Eidelberg, D; Ishikawa, T; Smith, D; Winterkorn, JS | 1 |
| Azari, NP; Pietrini, P | 1 |
| Diederich, N; Heiss, WD; Herholz, K; Karbe, H; Rudolf, J; Staffen, W | 1 |
| Hatazawa, J; Iwase, M; Kado, H; Kanno, I; Ogawa, T; Okudera, T; Uemura, K | 1 |
| Fujiwara, T; Ido, T; Itoh, M; Itoyama, Y; Iwata, R; Kimura, I; Nagasawa, H; Nomura, H; Saito, H; Tanji, H; Tuji, S | 1 |
| Degueldre, C; Destée, A; Franck, G; Garraux, G; Kreisler, A; Lemaire, C; Peigneux, P; Salmon, E | 1 |
| Cederbaum, J; Dhawan, V; Eidelberg, D; Fahn, S; Ginos, JZ; Greene, P; Moeller, JR; Powers, JM; Sidtis, JJ; Strother, SC | 1 |
| Kato, M | 1 |
| Hawkins, RA; Kuhl, DE; Metter, EJ; Riege, WH | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and Basal Ganglia Diseases
| Article | Year |
|---|---|
Basal ganglia involvement in temporal lobe epilepsy: a functional and morphologic study.
Topics: Adolescent; Adult; Basal Ganglia; Basal Ganglia Diseases; Dihydroxyphenylalanine; Dopamine; Down-Regulation; Energy Metabolism; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neostriatum; Neural Pathways; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Substantia Nigra | 2008 |
28 other study(ies) available for fluorodeoxyglucose f18 and Basal Ganglia Diseases
| Article | Year |
|---|---|
Brainstem atrophy is linked to extrapyramidal symptoms in frontotemporal dementia.
Topics: Atrophy; Basal Ganglia Diseases; Brain Stem; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging; Retrospective Studies | 2022 |
Multiple System Atrophy: Phenotypic spectrum approach coupled with brain 18-FDG PET.
Topics: Accidental Falls; Aged; Basal Ganglia Diseases; Brain; Cerebellar Diseases; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Hypotension, Orthostatic; Laryngeal Diseases; Latent Class Analysis; Male; Middle Aged; Multiple System Atrophy; Muscular Atrophy, Spinal; Pharyngeal Diseases; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; REM Sleep Behavior Disorder; Retrospective Studies; Spinal Curvatures; Urinary Incontinence | 2019 |
Cognitive reserve maps the core loci of neurodegeneration in corticobasal degeneration.
Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Cognitive Reserve; Female; Fluorodeoxyglucose F18; Humans; Male; Nerve Degeneration; Positron-Emission Tomography | 2018 |
A disease-specific metabolic brain network associated with corticobasal degeneration.
Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Cerebral Cortex; Cerebrum; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Networks and Pathways; Middle Aged; Multiple System Atrophy; Nerve Net; Neurodegenerative Diseases; Parkinsonian Disorders; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Supranuclear Palsy, Progressive | 2014 |
Evaluation of an optimized [
Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neurodegenerative Diseases; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2017 |
Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses.
Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Brain; Carbon Radioisotopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Glucose; Humans; Hypokinesia; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Mesencephalon; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tropanes | 2009 |
Occurrence of basal ganglia germ cell tumors without a mass.
Topics: Adolescent; Age Distribution; Age Factors; Antineoplastic Agents; Asian People; Atrophy; Basal Ganglia; Basal Ganglia Diseases; Brain Neoplasms; Brain Stem; Calcinosis; Child; Dementia; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Paresis; Positron-Emission Tomography; Radiotherapy | 2009 |
Glucose metabolism in progressive nonfluent aphasia with and without parkinsonism.
Topics: Aged; Basal Ganglia Diseases; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Primary Progressive Nonfluent Aphasia; Radiopharmaceuticals; Retrospective Studies; Supranuclear Palsy, Progressive | 2010 |
Sporadic corticobasal syndrome with progranulin mutation presenting as progressive apraxic agraphia.
Topics: Agraphia; Basal Ganglia Diseases; Brain; Female; Fluorodeoxyglucose F18; Functional Laterality; Handwriting; Humans; Intercellular Signaling Peptides and Proteins; Magnetic Resonance Imaging; Middle Aged; Mutation; Neuropsychological Tests; Positron-Emission Tomography; Progranulins; Radiopharmaceuticals | 2011 |
Comparison of clinical types of Wilson's disease and glucose metabolism in extrapyramidal motor brain regions.
Topics: Adult; Aged; Basal Ganglia; Basal Ganglia Diseases; Cerebellum; Female; Fluorodeoxyglucose F18; Glucose; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Is FDG-PET a useful tool in clinical practice for diagnosing corticobasal ganglionic degeneration?
Topics: Aged; Basal Ganglia Diseases; Cerebral Cortex; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Acute bilateral basal ganglia lesions in patients with diabetic uremia: an FDG-PET study.
Topics: Acute Disease; Aged; Basal Ganglia; Basal Ganglia Diseases; Diabetic Nephropathies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uremia | 2004 |
Subacute dementia and imaging correlates in a case of Fahr's disease.
Topics: Aggression; Anxiety; Basal Ganglia Diseases; Calcinosis; Cognition Disorders; Dementia; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Social Behavior; Syndrome; Tomography, Emission-Computed | 2004 |
Imaging of the corpus striatum without any activity at 192 MBq 18F-fluorodeoxyglucose PET after intoxication.
Topics: Adult; Basal Ganglia Diseases; Brain Mapping; Corpus Striatum; Diphenhydramine; Female; Fluorodeoxyglucose F18; Humans; Hypnotics and Sedatives; Myoclonus; Positron-Emission Tomography; Radiopharmaceuticals; Suicide, Attempted | 2005 |
Hyperglycemia-induced unilateral basal ganglion lesions with and without hemichorea. A PET study.
Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Chorea; Female; Fluorodeoxyglucose F18; Humans; Hyperglycemia; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction.
Topics: Adult; Aged; Basal Ganglia; Basal Ganglia Diseases; Blood Glucose; Chromosome Aberrations; Copper; Extrapyramidal Tracts; Female; Fluorodeoxyglucose F18; Genes, Recessive; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurodegenerative Diseases; Olfaction Disorders; Olfactory Pathways; Parkinsonian Disorders; Positron-Emission Tomography; Sensory Thresholds; Statistics as Topic | 2006 |
Neuropsychological and 18FDG-PET studies in a family with idiopathic basal ganglia calcifications.
Topics: Adult; Aged; Basal Ganglia; Basal Ganglia Diseases; Brain Mapping; Calcinosis; Case-Control Studies; Family Health; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2007 |
Behavioral correlates of posteromedial parietal cortex hypometabolism in a family with idiopathic basal ganglia calcifications.
Topics: Affective Symptoms; Basal Ganglia Diseases; Behavior; Calcinosis; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nerve Net; Parietal Lobe; Positron-Emission Tomography; Radiopharmaceuticals; Schizophrenic Psychology | 2008 |
Imaging local brain function with emission computed tomography.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Brain; Cerebrovascular Disorders; Child, Preschool; Dementia; Deoxyglucose; Depressive Disorder; Epilepsy; Female; Fluorine; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Radioisotopes; Tomography, Emission-Computed | 1984 |
Lid opening apraxia is associated with medial frontal hypometabolism.
Topics: Aged; Apraxias; Basal Ganglia Diseases; Blepharoptosis; Blepharospasm; Blood Glucose; Brain; Deoxyglucose; Dominance, Cerebral; Eyelids; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Male; Pyramidal Tracts; Tomography, Emission-Computed | 1995 |
Preclinical stages in subjects at risk for neurological disorders: can PET-FDG tell us more?
Topics: Adult; Alzheimer Disease; Basal Ganglia Diseases; Brain; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Tomography, Emission-Computed | 1995 |
[Functional significance of calcinosis of the basal ganglia via positron emission tomography].
Topics: Adult; Basal Ganglia; Basal Ganglia Diseases; Blood Glucose; Brain; Calcinosis; Dementia; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurologic Examination; Tomography, Emission-Computed | 1994 |
Radiation-induced meningioma evaluated with positron emission tomography with fludeoxyglucose F 18.
Topics: Adult; Basal Ganglia Diseases; Brain Neoplasms; Choristoma; Cranial Irradiation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Germinoma; Glucose; Humans; Male; Meningeal Neoplasms; Meningioma; Neoplasms, Radiation-Induced; Tomography, Emission-Computed | 1996 |
PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration.
Topics: Aged; Apraxias; Atrophy; Basal Ganglia; Basal Ganglia Diseases; Brain Diseases; Cerebral Cortex; Cerebrovascular Circulation; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Nerve Degeneration; Tomography, Emission-Computed | 1996 |
Voxel-based distribution of metabolic impairment in corticobasal degeneration.
Topics: Adult; Aged; Aged, 80 and over; Basal Ganglia Diseases; Blood Glucose; Brain; Brain Diseases, Metabolic; Case-Control Studies; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Net; Neurodegenerative Diseases; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 2000 |
The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.
Topics: Aged; Apraxias; Basal Ganglia Diseases; Blood Glucose; Cerebral Cortex; Deoxyglucose; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Muscle Rigidity; Nerve Degeneration; Neurologic Examination; Parkinson Disease, Secondary; Pyramidal Tracts; Tomography, Emission-Computed; Tremor | 1991 |
[Positron emission tomography and basal ganglia functions].
Topics: Animals; Basal Ganglia; Basal Ganglia Diseases; Corpus Striatum; Deoxyglucose; Dopamine; Energy Metabolism; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Macaca mulatta; Mice; Parkinson Disease; Rats; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1990 |
Determinations of cerebral glucose utilization in dementia using positron emission tomography.
Topics: Aged; Alzheimer Disease; Basal Ganglia Diseases; Blood Glucose; Dementia; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed | 1985 |